Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. Co. offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Co. operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. We show 58 historical shares outstanding datapoints in our BIO shares outstanding history coverage, used to compute BIO market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BIO market cap history over the course of time is important for investors
interested in comparing BIO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BIO versus a peer is one thing; comparing
BIO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BIO can fluctuate over the course of history.
With this page we aim to empower investors researching BIO by allowing them to research the BIO market cap history. |
Free BIO Email Alerts:
Video: The Importance of Market Cap
